Suppr超能文献

健康患者气管插管后减轻血流动力学变化的静脉注射羟考酮最佳剂量:一项随机对照试验。

Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: A randomized controlled trial.

作者信息

Park Yong-Hee, Lee Seung-Hyuk, Lee Oh Haeng, Kang Hyun, Shin Hwa-Yong, Baek Chong-Wha, Jung Yong Hun, Woo Young Cheol

机构信息

Department of Anesthesiology and Pain Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.

出版信息

Medicine (Baltimore). 2017 Mar;96(11):e6234. doi: 10.1097/MD.0000000000006234.

Abstract

BACKGROUND

Intravenous oxycodone has been used as an adjunct to anesthetic agents. This study aimed to assess the optimal dose of intravenous oxycodone for the attenuation of the hemodynamic responses to laryngoscopy and endotracheal intubation.

METHODS

A prospective, randomized, double-blind study was conducted. Ninety-five patients were randomly divided into 5 groups based on the oxycodone dose: 0, 0.05, 0.1, 0.15, 0.2 mg/kg. After administering the assigned dose of intravenous oxycodone, anesthesia was induced with thiopental. Heart rate (HR) and blood pressure (BP) were measured at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The percentage increase of BP was calculated as (highest BP after intubation - baseline BP)/baseline BP × 100 (%). The percentage increase of HR was calculated in same formula as above. Hypertension was defined as a 15% increase of systolic BP from baseline, and probit analysis was conducted.

RESULTS

Hemodynamic data from 86 patients were analyzed. The percentage increase of mean arterial pressure after intubation in groups 0.05, 0.1, 0.15, and 0.2 was significantly different from that in the control (P < 0.001). For HR, the percentage increase was lower than control group when oxycodone was same or more than 0.1 mg/kg (P < 0.05). Using probit analysis, the 95% effective dose (ED95) for preventing hypertension was 0.159 mg/kg (95% confidence interval [CI], 0.122-0.243). In addition, ED50 was 0.020 mg/kg (95% CI, -0.037 to 0.049). However, oxycodone was not effective for maintaining the HR in our study dosage. There were no significant differences in the incidence of hypotension during induction between groups.

CONCLUSIONS

Using 0.1 mg/kg of intravenous oxycodone is sufficient to attenuate the increase of BP and HR during induction period in healthy patients. The ED95, which was 0.159 mg/kg, can be useful to adjust the dosage of IV oxycodone for maintain stable BP during induction of general anesthesia.

摘要

背景

静脉注射羟考酮已被用作麻醉剂的辅助药物。本研究旨在评估静脉注射羟考酮减轻喉镜检查和气管插管引起的血流动力学反应的最佳剂量。

方法

进行了一项前瞻性、随机、双盲研究。95例患者根据羟考酮剂量随机分为5组:0、0.05、0.1、0.15、0.2mg/kg。给予指定剂量的静脉注射羟考酮后,用硫喷妥钠诱导麻醉。在基线、插管前以及插管后1、2和3分钟测量心率(HR)和血压(BP)。BP的升高百分比计算为(插管后最高BP - 基线BP)/基线BP×100(%)。HR的升高百分比按上述相同公式计算。高血压定义为收缩压较基线升高15%,并进行概率分析。

结果

分析了86例患者的血流动力学数据。0.05、0.1、0.15和0.2mg/kg组插管后平均动脉压的升高百分比与对照组相比有显著差异(P<0.001)。对于HR,当羟考酮剂量为0.1mg/kg及以上时,升高百分比低于对照组(P<0.05)。使用概率分析,预防高血压的95%有效剂量(ED95)为0.159mg/kg(95%置信区间[CI],0.122 - 0.243)。此外,ED50为0.020mg/kg(95%CI, - 0.037至0.049)。然而,在我们的研究剂量下,羟考酮对维持HR无效。各组诱导期间低血压的发生率无显著差异。

结论

对于健康患者,静脉注射0.1mg/kg的羟考酮足以减轻诱导期BP和HR的升高。ED95为0.159mg/kg,可用于调整静脉注射羟考酮的剂量,以在全身麻醉诱导期间维持BP稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/5369887/406c55fe6ed3/medi-96-e6234-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验